Tangka Florence K L, Subramanian Sujha, Hoover Sonja, DeGroff Amy, Joseph Djenaba, Wong Faye L, Richardson Lisa C
Centers for Disease Control and Prevention, Atlanta, GA, USA.
RTI International, Waltham, MA, USA.
Health Promot Pract. 2020 Nov;21(6):877-883. doi: 10.1177/1524839920954168. Epub 2020 Sep 29.
The Centers for Disease Control and Prevention (CDC) has a long-standing commitment to increase colorectal cancer (CRC) screening for vulnerable populations. In 2005, the CDC began a demonstration in five states and, with lessons learned, launched a national program, the Colorectal Cancer Control Program (CRCCP), in 2009. The CRCCP continues today and its current emphasis is the implementation of evidence-based interventions to promote CRC screening. The purpose of this article is to provide an overview of four CRCCP awardees and their federally qualified health center partners as an introduction to the accompanying series of research briefs where we present individual findings on impacts of evidence-based interventions on CRC screening uptake for each awardee. We also include in this article the conceptual framework used to guide our research. Our findings contribute to the evidence base and guide future program implementation to improve sustainability, increase CRC screening, and address disparities in screening uptake.
美国疾病控制与预防中心（CDC）长期致力于增加对弱势群体的结直肠癌（CRC）筛查。2005年，CDC在五个州开展了一项示范项目，并在吸取经验教训后，于2009年启动了一项全国性计划——结直肠癌控制计划（CRCCP）。CRCCP一直持续至今，其当前重点是实施基于证据的干预措施以促进CRC筛查。本文旨在概述四位CRCCP获奖者及其联邦合格健康中心合作伙伴，作为对随附系列研究简报的介绍，在这些简报中，我们将展示每位获奖者基于证据的干预措施对CRC筛查接受率影响的具体研究结果。我们还在本文中纳入了用于指导我们研究的概念框架。我们的研究结果为证据库做出了贡献，并指导未来的项目实施，以提高可持续性、增加CRC筛查并解决筛查接受率方面的差异。
